Turn Therapeutics sells 135,000 shares in private placement for $1.35 million

TTRX•2026-08-17

Private placement terms

Turn Therapeutics entered securities purchase agreements on Aug. 14, 2026 for a private placement of common stock.

Accredited investors agreed to buy 135,000 shares at $10 per share for $1.35 million in gross proceeds.

Investors and offering details

The buyers were existing series and seed investors.

The shares were sold in an unregistered offering under Section 4(a)(2) and Regulation D. Investors received registration rights covering the shares.

Sources

Turn Therapeutics sells 135,000 shares in private placement for $1.35 million

Sec

Turn Therapeutics sells 135,000 shares in private placement for $1.35 million

Private placement terms

Investors and offering details

Related News

Sagimet Biosciences grants 260,700 inducement stock options to new hires

ImageneBio grants 144,000 RSUs, 112,525 stock options to new hires under inducement plan

EON Resources delays Q2 10-Q filing, seeks 5-day extension

Sources

Turn Therapeutics sells 135,000 shares in private placement for $1.35 million

ServiceNow director Paul Edward Chamberlain disposes of 1,500 shares worth $188,400

Xos wins first U.S. Air Force contract for deployable mobile charging prototype